Yiling Zhang

Yiling Zhang (张逸凌) is the founder and CEO of Changmugu (长木谷), an orthopedic AI company building AI-powered surgical solutions. According to FreeS Fund's coverage, he holds a doctorate in orthopedic medicine and was a postdoctoral researcher at Harvard Medical School — where, as he recounted at a FreeS event, he was doing AI surgical-solution work in 2018 when FreeS's "Feng Shu" persuaded him to skip a US professorship and return to China to start the company instead . Changmugu, which he describes as a classic medicine-plus-engineering team of medical scientists and AI engineers from schools like Harvard, Stanford, Tsinghua, and Peking University, raised a tens-of-millions-RMB Pre-A round reported by FreeS in September 2019, with Zhang arguing the hardest part of medical AI is product landing — understanding orthopedic surgeons' real clinical pain points . elsewhere's corpus has no material on him after 2020.